Diakine-DK4 10 (VEGFR2)

N/A

Report date: 2023/03/07 16:09:40

Base Information

Drug NameDiakine-DK4 10 (VEGFR2)

Drug Alias NameDiakine™- DK4 10 (VEGFR2)Diakine™- DK410 (VEGFR2)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionInterleukin-4 receptors stimulantsInterleukin 10 receptor stimulantsAnti-Vascular endothelial growth factor receptor 2

TargetsInterleukin-4 receptorsInterleukin 10 receptorVascular endothelial growth factor receptor 2

Therapy Area/IndicationsPsoriasisArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsPsoriasisArthritis, Rheumatoid

Inactive IndicationsN/A

ATC CodeN/A